These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18417837)

  • 1. Debate on the various anti-vascular endothelial growth factor drugs.
    Khalili MR; Hosseini H
    Indian J Ophthalmol; 2008; 56(3):255-6; author reply 256. PubMed ID: 18417837
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).
    Nagpal M; Nagpal K; Nagpal PN
    Indian J Ophthalmol; 2007; 55(6):437-9. PubMed ID: 17951900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-VEGF therapeutic approaches for diabetic macular edema.
    Khurana RN; Do DV; Nguyen QD
    Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of neovascular age-related macular degeneration with bevacizumab].
    Monzón Moreno A
    Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-VEGF therapy in proliferative diabetic retinopathy.
    Abdallah W; Fawzi AA
    Int Ophthalmol Clin; 2009; 49(2):95-107. PubMed ID: 19349790
    [No Abstract]   [Full Text] [Related]  

  • 6. [VEGF inhibitors in ophthalmology].
    Thys J; Dupont G; Rakic JM
    Rev Med Liege; 2009; 64(5-6):323-6. PubMed ID: 19642468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of ocular neovascularization: promises and potential problems.
    van Wijngaarden P; Coster DJ; Williams KA
    JAMA; 2005 Mar; 293(12):1509-13. PubMed ID: 15784876
    [No Abstract]   [Full Text] [Related]  

  • 8. New treatments for age-related macular degeneration.
    Avery RL
    Lancet; 2007 Oct; 370(9597):1479-80; author reply 1480. PubMed ID: 17964341
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.
    Nelson M
    Retina; 2010 Feb; 30(2):380; author reply 380-1. PubMed ID: 20142719
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiangiogenic therapy in neovascular age-related macular degeneration.
    Lin RC; Rosenfeld PJ
    Int Ophthalmol Clin; 2007; 47(1):117-37. PubMed ID: 17237677
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration.
    Jeganathan VS; Verma N
    Curr Opin Ophthalmol; 2009 May; 20(3):223-5. PubMed ID: 19367163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.
    Chong V
    Ophthalmologica; 2012; 227 Suppl 1():2-10. PubMed ID: 22517120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related macular degeneration: therapeutic hopes].
    Behar-Cohen F; Sennlaub F; Berdugo M
    Med Sci (Paris); 2007 Feb; 23(2):127-9. PubMed ID: 17291419
    [No Abstract]   [Full Text] [Related]  

  • 14. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.
    Kaiser PK
    Am J Ophthalmol; 2006 Oct; 142(4):660-8. PubMed ID: 17011860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diabetic retinopathy with anti-VEGF drugs.
    Waisbourd M; Goldstein M; Loewenstein A
    Acta Ophthalmol; 2011 May; 89(3):203-7. PubMed ID: 21044274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical update: new treatments for age-related macular degeneration.
    Wong TY; Liew G; Mitchell P
    Lancet; 2007 Jul; 370(9583):204-206. PubMed ID: 17658379
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of neovascular age-related macular degeneration with pegaptanib and boosting with bevacizumab or ranibizumab as needed.
    Farah SE
    Ophthalmic Surg Lasers Imaging; 2008; 39(4):294-8. PubMed ID: 18717434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Brunetti M
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.
    Ip MS; Scott IU; Brown GC; Brown MM; Ho AC; Huang SS; Recchia FM;
    Ophthalmology; 2008 Oct; 115(10):1837-46. PubMed ID: 18929163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current state and issues of medical treatment for age-related macular degeneration].
    Ishida S
    Nihon Yakurigaku Zasshi; 2008 Jan; 131(1):47-9. PubMed ID: 18187884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.